CDIVX
Price
$12.57
Change
+$0.05 (+0.40%)
Updated
Jun 2 closing price
Net Assets
25.85M
FSMAX
Price
$115.66
Change
+$1.23 (+1.07%)
Updated
Jun 2 closing price
Net Assets
42.73B
Interact to see
Advertisement

CDIVX vs FSMAX

Header iconCDIVX vs FSMAX Comparison
Open Charts CDIVX vs FSMAXBanner chart's image
CDIVX vs FSMAX Comparison Chart in %
View a ticker or compare two or three
VS
CDIVX vs. FSMAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIVX is a Hold and FSMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. CDIVX (25.9M). FSMAX pays higher dividends than CDIVX: FSMAX (0.50) vs CDIVX (0.00). CDIVX was incepted earlier than FSMAX: CDIVX (13 years) vs FSMAX (15 years). CDIVX (1.77) is less costly to investors than FSMAX (0.04). CDIVX is a more actively managed with annual turnover of: 27.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than CDIVX: FSMAX (0) vs CDIVX (25000). FSMAX annual gain was more profitable for investors over the last year : 30.08 vs. CDIVX (3.39). FSMAX return over 5 years is better than : 37.47 vs. CDIVX (-6.51).
CDIVXFSMAXCDIVX / FSMAX
Total Expense Ratio1.050.043,000%
Annual Report Gross Expense Ratio1.770.045,057%
Fund Existence13 years15 years-
Gain YTD4.50814.89030%
Front LoadN/AN/A-
Min. Initial Investment250000-
Min. Initial Investment IRAN/AN/A-
Net Assets25.9M42.7B0%
Annual Yield % from dividends0.000.50-
Returns for 1 year3.3930.0811%
Returns for 3 years8.7373.3812%
Returns for 5 years-6.5137.47-17%
Returns for 10 years6.23143.954%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGGX50.46N/A
N/A
American Funds Intl Gr and Inc R6
CMUAX17.28N/A
N/A
Columbia Select Mid Cap Value A
GPGIX3.89N/A
N/A
Grandeur Peak Global Opportunities Instl
CIGYX11.41N/A
N/A
AB International Growth Advisor
HFDRX21.05N/A
N/A
Hartford Schroders US MidCap Opps R3